Improved systems for generating and evaluating adenovirus vaccine vectors reveal differences in immunogenicity between vectors of different adenoviral species

Improved systems for generating and evaluating adenovirus vaccine vectors reveal differences in immunogenicity between vectors of different adenoviral species

Bibliografiset tiedot
Päätekijät:	Dicks, M, Spencer, A, Edwards, N, Gilbert, S, Hill, S, Cottingham, MG
Aineistotyyppi:	Journal article
Julkaistu:	2011

Samankaltaisia teoksia

Uncovering the mechanisms of adenovirus vector immunogenicity
Tekijä: Dicks, M, et al.
Julkaistu: (2013)

A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity.
Tekijä: Dicks, M, et al.
Julkaistu: (2012)

A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity.
Tekijä: Matthew D J Dicks, et al.
Julkaistu: (2012-01-01)

STING-pathway modulation to enhance the immunogenicity of adenoviral-vectored vaccines
Tekijä: Eriko Padron-Regalado, et al.
Julkaistu: (2022-08-01)

Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice.
Tekijä: Warimwe, G, et al.
Julkaistu: (2013)

The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species.
Tekijä: Dicks, M, et al.
Julkaistu: (2015)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
Tekijä: Ewer (nee Russell), K, et al.
Julkaistu: (2017)

Novel adenovirus vaccine vectors
Tekijä: Dicks, M
Julkaistu: (2013)

Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice
Tekijä: Dicks, M, et al.
Julkaistu: (2015)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
Tekijä: Katie Ewer, et al.
Julkaistu: (2017-12-01)

Simian adenoviruses as vaccine vectors
Tekijä: Morris, S, et al.
Julkaistu: (2016)

Simian adenoviruses as vaccine vectors
Tekijä: Morris, S, et al.
Julkaistu: (2016)

Long-term thermostabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glass.
Tekijä: Alcock, R, et al.
Julkaistu: (2010)

Adenoviral vectors as novel vaccines for influenza.
Tekijä: Coughlan, L, et al.
Julkaistu: (2015)

Immunogenicity and cross-reactivity of rhesus adenoviral vectors
Tekijä: Iampietro, M, et al.
Julkaistu: (2018)

Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines
Tekijä: Lynda Coughlan
Julkaistu: (2020-05-01)

Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster
Tekijä: Marta Ulaszewska, et al.
Julkaistu: (2023-01-01)

MAIT cell activation augments adenovirus vector vaccine immunogenicity
Tekijä: Provine, N, et al.
Julkaistu: (2021)

EVALUATION OF SIMIAN ADENOVIRAL VECTOR ADCH63 EXPRESSING MSP-1 AS A CANDIDATE BLOOD-STAGE MALARIA VACCINE
Tekijä: Goodman, A, et al.
Julkaistu: (2009)

Development of novel vaccine vectors: Chimpanzee adenoviral vectors
Tekijä: Jingao Guo, et al.
Julkaistu: (2018-07-01)

Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei.
Tekijä: Reyes-Sandoval, A, et al.
Julkaistu: (2008)

Adenovirus vector and mRNA vaccines: mechanisms regulating their immunogenicity
Tekijä: Provine, NM, et al.
Julkaistu: (2022)

Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors
Tekijä: Cottingham, MG, et al.
Julkaistu: (2011)

Preventing spontaneous genetic rearrangements in the transgene cassettes of adenovirus vectors.
Tekijä: Cottingham, MG, et al.
Julkaistu: (2012)

Mixed vector immunization with recombinant adenovirus and MVA can improve vaccine efficacy while decreasing antivector immunity.
Tekijä: Reyes-Sandoval, A, et al.
Julkaistu: (2012)

Mixed vector immunization with recombinant adenovirus and MVA can improve vaccine efficacy while decreasing antivector immunity
Tekijä: Reyes-Sandoval, A, et al.
Julkaistu: (2012)

Correction: Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei
Tekijä: Reyes-Sandoval, A, et al.
Julkaistu: (2011)

Transgene optimization, immunogenicity and in vitro efficacy of viral vectored vaccines expressing two alleles of Plasmodium falciparum AMA1.
Tekijä: Biswas, S, et al.
Julkaistu: (2011)

Utilizing poxviral vectored vaccines for antibody induction-progress and prospects.
Tekijä: Draper, S, et al.
Julkaistu: (2013)

Safety and immunogenicity of adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies
Tekijä: Folegatti, P, et al.
Julkaistu: (2021)

Using multivalent adenoviral vectors for HIV vaccination.
Tekijä: Linlin Gu, et al.
Julkaistu: (2013-01-01)

An Adenoviral Vector Based Vaccine for Rhodococcus equi.
Tekijä: Carla Giles, et al.
Julkaistu: (2016-01-01)

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
Tekijä: Folegatti, P, et al.
Julkaistu: (2019)

Immunogenicity of a pre-erythrocytic-stage malaria insert ME-trap encoded by novel simian adenoviral vectors
Tekijä: Reyes-Sandoval, A, et al.
Julkaistu: (2005)

Safety and Immunogenicity of Adenovirus and Poxvirus Vectored Vaccines against a Mycobacterium Avium Complex Subspecies
Tekijä: Pedro M. Folegatti, et al.
Julkaistu: (2021-03-01)

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
Tekijä: Pedro M. Folegatti, et al.
Julkaistu: (2019-05-01)

Adenovirus Specific Pre-Immunity Induced by Natural Route of Infection Does Not Impair Transduction by Adenoviral Vaccine Vectors in Mice.
Tekijä: Bruna de Andrade Pereira, et al.
Julkaistu: (2015-01-01)

Pandemic-response adenoviral vector and RNA vaccine manufacturing
Tekijä: Zoltán Kis, et al.
Julkaistu: (2022-03-01)

The use of adenoviral vectors in gene therapy and vaccine approaches
Tekijä: Natália Meneses Araújo, et al.
Julkaistu: (2022-10-01)

Adenoviral Vector-Based Vaccine Platforms for Developing the Next Generation of Influenza Vaccines
Tekijä: Ekramy E. Sayedahmed, et al.
Julkaistu: (2020-10-01)